Anbio Biotechnology (NASDAQ:NNNN – Get Free Report)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $25.80, but opened at $24.59. Anbio Biotechnology shares last traded at $25.0050, with a volume of 388 shares.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings lowered Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, April 1st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Anbio Biotechnology presently has a consensus rating of “Sell”.
Check Out Our Latest Stock Report on Anbio Biotechnology
Anbio Biotechnology Price Performance
Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) last issued its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share for the quarter.
About Anbio Biotechnology
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Recommended Stories
- Five stocks we like better than Anbio Biotechnology
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
- 3 Sectors That Look Most Vulnerable Ahead of May 15
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
